The CDC has updated its HIV testing guidance, emphasizing routine, opt-out screening for patients aged 13–64 and more frequent testing for those at higher risk. The approach aims to reduce stigma, ...

Data from ARTISTRY trials demonstrated that switching to a single-tablet regimen of bictegravir and lenacapavir is noninferior to continuing current antiretroviral therapy.

Lenacapavir: a game changer in SA’s fight against HIV While Health Minister, Dr Aaron Motsoaledi, is still to announce the date for the launch of the game changing HIV prevention medication ...